Early apoptosis in intestinal and diffuse gastric carcinomas.

Hongqiang Zhou,Xu Wang,N. Zhang
DOI: https://doi.org/10.3748/WJG.V6.I6.898
IF: 5.374
2000-12-15
World Journal of Gastroenterology
Abstract:Apoptosis, described by Kerr[1] in 1972, plays a key role in all types of regulated cellular processes in multicellular organisms. It is defined as a morphologic change, including fragmentation of the DNA, cell shrinkage, dilation of the endoplasmatic reticulum, cell fragmentation and formation of apoptotic bodies[2,3]. One of the abilities of apoptotic cell is to trigger its own engulfment by phagocytic cells prior to cell lysis, which is crucial to the avoidance of the tissue damage and inflammation associated with necrosis[4]. Apoptotic cells lose membrane phospholipid asymmetry and expose phosphatidylserine (PS) on the outer leaflet of the plasma membrane, macrophages then phagocytose apoptotic cells after specific recognition of the exposed PS[5]. Annexin V (AV), having a high affinity for PS in the presence of Ca2+ ions[6] and inhibition to PS-dependent procoagulant reactions[7], is proved to be a very useful general probe for early apoptosis-associated membrane change on live cells before the nuclear condensation events and fragmentation of the DNA[8]. Gastric carcinoma is estimated to be one of the most frequent cancers in the world. According to Lanren’s classification[9], gastric carcinoma can be divided into adenocarcinomas of diffuse and intestinal type, which differ in growth pattern, morphology, and some phenotypic markers. Recently, apoptotic index and apoptotic genes have been found different in both types[10,11]. In this study, we investigated the quantitations of early apoptosis in both intestinal and diffuse gastric carcinoma and their adjacent non-neoplastic tissues with regard to classification and differentiation, and whether the exposure of PS could be inhibited by Bcl-2 protein through various pathways.
What problem does this paper attempt to address?